Dr Michael O’Sullivan

Dr Michael O’Sullivan is a Consultant Cardiologist at Addenbrookes Hospital, Cambridge. Following undergraduate training at Cambridge University, Dr O’Sullivan undertook postgraduate medical training at Royal Brompton National Heart & Lung Hospital and the Oxford University Teaching Hospitals. He returned to Cambridge in 1996 and over the next seven years trained in all aspects of cardiology, with particular emphasis on interventional cardiology, at Papworth and Addenbrooke’s Hospitals. During this period he was awarded a PhD, and the British Cardiac Society Young Research Worker’s Prize, for research into mechanisms of coronary stent failure. From 2003-2004, he worked in the Department of Interventional Cardiology at University of British Columbia, Vancouver and gained extensive experience in advanced interventional techniques and new strategies for the treatment of coronary disease. Following his return, he was appointed Consultant Cardiologist at Addenbrooke’s and Papworth Hospitals. In this position, he provides secondary and tertiary centre care to patients with general cardiac problems (valve disease, heart failure, heart rhythm problems), in addition to those with coronary disease. Dr O’Sullivan was appointed Director of Cardiology at Addenbrookes in 2006 and is Clinical Director of the Cambridge Heart Clinic.

Date of first medical qualification1992
Primary Medical QualificationBChir 1992 University of Cambridge
MB 1993 University of Cambridge
GMC Reference Number3673168
Main SpecialtyCardiology
Sub-specialtyInterventional cardiology
Current Posts Consultant Cardiologist and Director of Cardiology, Addenbrooke’s Hospital, Cambridge

Consultant Cardiologist, Papworth Hospital NHS Foundation Trust, Cambridgeshire
Clinical Director, Cambridge Heart Clinic

Current Memberships & FellowshipsRoyal College of Physicians
British Cardiac Society
British Cardiovascular Intervention Society
ResearchEmerging strategies and technologies in interventional cardiology; mechanisms of coronary disease and in-stent restenosis; new technologies for treatment .of valvular heart disease
Outpatient ClinicsTuesday 2pm – 5pm